Literature DB >> 2507625

Can price controls induce optimal physician behavior?

G Wedig1, J B Mitchell, J Cromwell.   

Abstract

Recently, budget-conscious policymakers have shifted their attention to the physician services market and have begun to consider a wide variety of price regulatory schemes for moderating expenditures in this market. In a recent article in this journal, Feldman and Sloan warned that price controls on physician services may cause undesirable declines in service quality, independent of their budgetary ramifications. Our aim in this article is to reconsider the effects of price controls in the broader context of insurance coverage and moral hazard. Our ultimate goal is to assess the benefits of price controls independent of specific assumptions about the controversial issues of demand inducement and income targeting. Using a simple extension of the Feldman/Sloan model, we find that price controls can be and almost certainly are welfare-improving as long as consumers are sufficiently well insured, regardless of where one stands on the inducement issue. The salutary effects of price controls, on the other hand, can be compromised by income-targeting behavior on the part of physicians. We also introduce evidence from Medicare's recent fee freeze to evaluate the possibility of income-targeting behavior empirically. While formal studies of income targeting suggest that its magnitude is small in cross-section, we warn that its effects may be larger over time; this is what our descriptive evidence suggests. We conclude that more dramatic short-term progress on physician fee inflation will require stronger measures, such as putting physicians at risk for consumer expenditures.

Mesh:

Year:  1989        PMID: 2507625     DOI: 10.1215/03616878-14-3-601

Source DB:  PubMed          Journal:  J Health Polit Policy Law        ISSN: 0361-6878            Impact factor:   2.265


  4 in total

1.  The effects of fee bundling on dental utilization.

Authors:  J Porter; P C Coyte; J Barnsley; R Croxford
Journal:  Health Serv Res       Date:  1999-10       Impact factor: 3.402

2.  Impact of the Medicare Modernization Act of 2003 on utilization and spending for medicare part B-covered biologics in rheumatoid arthritis.

Authors:  Jalpa A Doshi; Pengxiang Li; Andrea Puig
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-03       Impact factor: 4.794

3.  Effects of the relative fee structure on the use of surgical operations.

Authors:  J J Escarce
Journal:  Health Serv Res       Date:  1993-10       Impact factor: 3.402

4.  Balance billing: the patients' perspective.

Authors:  Mathias Kifmann; Florian Scheuer
Journal:  Health Econ Rev       Date:  2011-09-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.